Capstone posts preliminary July–August organic revenue growth of 7.6% and gross profit growth of 6.5%
Bitget2026/10/01 12:56- Capstone Therapeutics Corporation flagged continued momentum in early Q3 2026.
- It projected additional revenue growth without a proportionate rise in its cost base as it expands its product portfolio and geographic reach through its distribution infrastructure.
- The outlook follows preliminary July–August results showing organic revenue up 7.6% year over year to about $14.0 million.
- Organic gross profit was up 6.5% to $3.5 million for July–August.
- Year to date through August 31, organic revenue rose 4.6% to about $48.1 million.
- Year to date through August 31, organic gross profit increased 6.5% to $12.5 million.
- Organic gross profit outpaced revenue growth despite contraction in the broader building-products market.
- The company plans to scale distribution in the Pacific Northwest.
- It plans to broaden Carolina Stone into siding.
- It plans to continue rolling out products such as Eldorado Stone to drive growth through existing infrastructure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Dollar Index slips from its 18-month high

Monnalisa shares delist from Euronext Growth Milan
Monnalisa’s delisting from trading on Euronext Growth Milan took effect today. The company is preparing a shareholder buyback process led by Modamet and Jafin Due for investors seeking to sell. Further details are due in coming days on the purchase window and a single settlement date for the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monnalisa S.p.A. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
ICE brings futures trading to London’s $190 billion-a-day physical gold market
Precia reports 5,733,040 issued shares, 8,350,574 exercisable voting rights as of Aug. 31, 2026
Precia disclosed 5,733,040 issued shares as of Aug. 31, 2026. Theoretical voting rights totaled 8,677,204. Exercisable voting rights stood at 8,350,574, reflecting 326,630 treasury shares without voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precia SA published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.